Former COO of Pharnext, a Euronext listed phase 3 neurology biotech. Amit has over 25 years of multifunctional experience across the pharmaceutical, MedTech and clinical diagnostics industry.
Finn is a commercial and clinical development expert taking products through First-in-man to regulatory approval and completing acquisition, partnering and licensing.
Oliver has a private equity and corporate finance background with emerging and entrepreneurial technology business. He is Co-founder of Antev Limited.
Peter is an experienced public company Finance Director and is currently Group Finance Director for AIM listed the MISSION Group plc.
Morten is an experienced investment manager, adviser, and board member with a demonstrated track record of more than 33 years success in the financial industry. He is an expert in business development, strategic planning and strategy, and asset management.
Olav is currently CEO of UK based stem cell focused biotech ReNeuron, prior to which he has held multiple senior roles in the pharmaceutical industry.